These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9436961)

  • 1. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis.
    Coffin CM; Rulon J; Smith L; Bruggers C; White FV
    Mod Pathol; 1997 Dec; 10(12):1175-87. PubMed ID: 9436961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS).
    Smith LM; Anderson JR; Coffin CM
    Med Pediatr Oncol; 2002 Jun; 38(6):398-404. PubMed ID: 11984800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression pattern of contractile and intermediate filament proteins in developing skeletal muscle and rhabdomyosarcoma of childhood: diagnostic and prognostic utility.
    Wijnaendts LC; van der Linden JC; van Unnik AJ; Delemarre JF; Voute PA; Meijer CJ
    J Pathol; 1994 Dec; 174(4):283-92. PubMed ID: 7884590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
    Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
    Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new marker for rhabdomyosarcoma. Insulin-like growth factor II.
    Yun K
    Lab Invest; 1992 Nov; 67(5):653-64. PubMed ID: 1434543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoglobin, desmin and vimentin in ultrastructurally proven rhabdomyomas and rhabdomyosarcomas. An immunohistochemical study utilizing a series of monoclonal and polyclonal antibodies.
    Seidal T; Kindblom LG; Angervall L
    Appl Pathol; 1987; 5(4):201-19. PubMed ID: 3689591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy associated differentiation in rhabdomyosarcomas.
    d'Amore ES; Tollot M; Stracca-Pansa V; Menegon A; Meli S; Carli M; Ninfo V
    Mod Pathol; 1994 Jan; 7(1):69-75. PubMed ID: 8159655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications.
    Godbole P; Outram A; Wilcox DT; Duffy PG; Sebire NJ
    J Urol; 2006 Oct; 176(4 Pt 2):1751-4. PubMed ID: 16945640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
    Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
    Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.
    Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H
    Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas.
    Skalli O; Gabbiani G; Babaï F; Seemayer TA; Pizzolato G; Schürch W
    Am J Pathol; 1988 Mar; 130(3):515-31. PubMed ID: 3279794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
    Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemically induced rhabdomyosarcomas in rats. Ultrastructural, immunohistochemical, biochemical features and expression of alpha-actin isoforms.
    Babai F; Skalli O; Schurch W; Seemayer TA; Gabbiani G
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(5):263-77. PubMed ID: 2901166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.
    Kumar S; Perlman E; Harris CA; Raffeld M; Tsokos M
    Mod Pathol; 2000 Sep; 13(9):988-93. PubMed ID: 11007039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
    Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
    Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL; Anderson J; Pappo AS; Meyer WH;
    J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orbital rhabdomyosarcoma. Immunohistochemical studies of seven cases.
    Sun XL; Zheng BH; Li B; Li LQ; Soejima K; Kanda M
    Chin Med J (Engl); 1990 Jun; 103(6):485-8. PubMed ID: 2119961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.